CHS INC - CHSINC 8 PERP (CHSCP) Fundamental Analysis & Valuation

NASDAQ:CHSCP • US12542R2094

Current stock price

27.62 USD
-0.01 (-0.04%)
Last:

This CHSCP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CHSCP Profitability Analysis

1.1 Basic Checks

  • CHSCP had a positive operating cash flow in the past year.
  • In the past 5 years CHSCP has always been profitable.
  • Each year in the past 5 years CHSCP had a positive operating cash flow.
CHSCP Yearly Net Income VS EBIT VS OCF VS FCFCHSCP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

1.2 Ratios

  • CHSCP has a Return On Assets of 2.96%. This is comparable to the rest of the industry: CHSCP outperforms 56.32% of its industry peers.
  • With a Return On Equity value of 5.48%, CHSCP perfoms like the industry average, outperforming 56.32% of the companies in the same industry.
  • CHSCP has a Return On Invested Capital of 0.37%. This is comparable to the rest of the industry: CHSCP outperforms 40.23% of its industry peers.
  • CHSCP had an Average Return On Invested Capital over the past 3 years of 3.89%. This is below the industry average of 7.23%.
Industry RankSector Rank
ROA 2.96%
ROE 5.48%
ROIC 0.37%
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
CHSCP Yearly ROA, ROE, ROICCHSCP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • CHSCP has a Profit Margin (1.75%) which is in line with its industry peers.
  • In the last couple of years the Profit Margin of CHSCP has grown nicely.
  • With a Operating Margin value of 0.21%, CHSCP is not doing good in the industry: 62.07% of the companies in the same industry are doing better.
  • CHSCP's Operating Margin has declined in the last couple of years.
  • The Gross Margin of CHSCP (3.21%) is worse than 85.06% of its industry peers.
  • CHSCP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.21%
PM (TTM) 1.75%
GM 3.21%
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
CHSCP Yearly Profit, Operating, Gross MarginsCHSCP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

2

2. CHSCP Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHSCP is destroying value.
  • The debt/assets ratio for CHSCP is higher compared to a year ago.
CHSCP Yearly Shares OutstandingCHSCP Yearly Shares OutstandingYearly Shares Outstanding 2018 2M 4M 6M 8M 10M
CHSCP Yearly Total Debt VS Total AssetsCHSCP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 2.11 indicates that CHSCP is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • CHSCP's Altman-Z score of 2.11 is in line compared to the rest of the industry. CHSCP outperforms 52.87% of its industry peers.
  • A Debt/Equity ratio of 0.32 indicates that CHSCP is not too dependend on debt financing.
  • The Debt to Equity ratio of CHSCP (0.32) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Altman-Z 2.11
ROIC/WACC0.07
WACC5.57%
CHSCP Yearly LT Debt VS Equity VS FCFCHSCP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • CHSCP has a Current Ratio of 1.42. This is a normal value and indicates that CHSCP is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of CHSCP (1.42) is comparable to the rest of the industry.
  • A Quick Ratio of 0.80 indicates that CHSCP may have some problems paying its short term obligations.
  • CHSCP has a Quick ratio (0.80) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 0.8
CHSCP Yearly Current Assets VS Current LiabilitesCHSCP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

1

3. CHSCP Growth Analysis

3.1 Past

  • Looking at the last year, CHSCP shows a decrease in Revenue. The Revenue has decreased by -5.74% in the last year.
  • CHSCP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.54% yearly.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-5.74%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-4.63%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSCP Yearly Revenue VS EstimatesCHSCP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

1

4. CHSCP Valuation Analysis

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSCP Price Earnings VS Forward Price EarningsCHSCP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CHSCP is valued cheaply inside the industry as 93.10% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.4
CHSCP Per share dataCHSCP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K 1.5K 2K 2.5K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

8

5. CHSCP Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 7.20%, CHSCP is a good candidate for dividend investing.
  • CHSCP's Dividend Yield is rather good when compared to the industry average which is at 2.45. CHSCP pays more dividend than 91.95% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, CHSCP pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.2%

5.2 History

  • CHSCP has paid a dividend for at least 10 years, which is a reliable track record.
  • CHSCP has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years21
CHSCP Yearly Dividends per shareCHSCP Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • CHSCP pays out 27.52% of its income as dividend. This is a sustainable payout ratio.
DP27.52%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCP Yearly Income VS Free CF VS DividendCHSCP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B 2.5B
CHSCP Dividend Payout.CHSCP Dividend Payout, showing the Payout Ratio.CHSCP Dividend Payout.PayoutRetained Earnings

CHSCP Fundamentals: All Metrics, Ratios and Statistics

CHS INC - CHSINC 8 PERP

NASDAQ:CHSCP (3/30/2026, 4:04:22 PM)

27.62

-0.01 (-0.04%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)01-06
Earnings (Next)03-31
Inst Owners10.86%
Inst Owner Change-0.8%
Ins Owners0.04%
Ins Owner Change0%
Market Cap338.90M
Revenue(TTM)35.03B
Net Income(TTM)613.61M
Analysts0
Price TargetN/A
Short Float %0.28%
Short Ratio1.92
Dividend
Industry RankSector Rank
Dividend Yield 7.2%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP27.52%
Div Incr Years0
Div Non Decr Years21
Ex-Date03-17
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF 0.57
P/B 0.03
P/tB 0.03
EV/EBITDA 2.4
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-4.86
FCFYN/A
OCF(TTM)48.25
OCFY174.67%
SpS2855.14
BVpS913.07
TBVpS913.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 2.96%
ROE 5.48%
ROCE 0.54%
ROIC 0.37%
ROICexc 0.38%
ROICexgc 0.38%
OM 0.21%
PM (TTM) 1.75%
GM 3.21%
FCFM N/A
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
ROICexc(3y)4.33%
ROICexc(5y)4.38%
ROICexgc(3y)4.41%
ROICexgc(5y)4.46%
ROCE(3y)5.12%
ROCE(5y)5.34%
ROICexgc growth 3Y-59.71%
ROICexgc growth 5Y-22%
ROICexc growth 3Y-59.75%
ROICexc growth 5Y-22.29%
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
F-Score4
Asset Turnover1.69
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Debt/EBITDA 4.81
Cap/Depr 96.64%
Cap/Sales 1.86%
Interest Coverage 250
Cash Conversion 79.1%
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 0.8
Altman-Z 2.11
F-Score4
WACC5.57%
ROIC/WACC0.07
Cap/Depr(3y)119.46%
Cap/Depr(5y)96.76%
Cap/Sales(3y)1.78%
Cap/Sales(5y)1.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.74%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-4.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-77.46%
EBIT growth 3Y-56.84%
EBIT growth 5Y-20.06%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-102.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-82.15%
OCF growth 3Y-31.13%
OCF growth 5Y-10.17%

CHS INC - CHSINC 8 PERP / CHSCP Fundamental Analysis FAQ

What is the fundamental rating for CHSCP stock?

ChartMill assigns a fundamental rating of 3 / 10 to CHSCP.


Can you provide the valuation status for CHS INC - CHSINC 8 PERP?

ChartMill assigns a valuation rating of 1 / 10 to CHS INC - CHSINC 8 PERP (CHSCP). This can be considered as Overvalued.


Can you provide the profitability details for CHS INC - CHSINC 8 PERP?

CHS INC - CHSINC 8 PERP (CHSCP) has a profitability rating of 4 / 10.


How sustainable is the dividend of CHS INC - CHSINC 8 PERP (CHSCP) stock?

The dividend rating of CHS INC - CHSINC 8 PERP (CHSCP) is 8 / 10 and the dividend payout ratio is 27.52%.